APO-50815
APO-50815 is a WEE1 kinase inhibitor with a human IC50 of 9 nM. APO-50815 induces DNA damage, replication stress, S-phase cell accumulation, and apoptosis. APO-50815 can be used for the research of metastatic colorectal cancer.
For research use only. We do not sell to patients.
- Formula: C28H29N7O2S
- Molecular Weight:527.64
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
APO-50815 (Compound 14) potently inhibits recombinant human WEE1 kinase with an IC50 of 9 nM, exhibits 10-fold selectivity for WEE1 over PLK1, and is inactive against CHK1 at concentrations up to 10 μM[1].
APO-50815 (100 pM-100 μM; 5 days) potently reduces viability of TP53-mutated peritoneal metastatic CRC organoid lines PM003 (IC50 = 37 nM) and PM025 (IC50 = 74 nM), with superior efficacy compared to clinical and preclinical WEE1 inhibitors[1].
APO-50815 (100 pM-100 μM; 5 days) potently reduces viability of TP53-mutated liver metastatic CRC organoid line QEH039LM (IC50 = 50 nM) and exhibits enhanced activity against the KRASG12X-mutated, WEE1 inhibitor-resistant line QEH042LM (IC50 = 633 nM), outperforming clinical WEE1 inhibitors[1].
APO-50815 (100 pM-100 μM; 5 days) potently and selectively reduces viability of primary CRC organoids across diverse mutation profiles, with exceptional therapeutic indices of 238 (RAH051), 146 (RAH035), and 129 (RAH057)[1].
APO-50815 (300 nM; 48 h) significantly reduces active cycling, amplifies DNA damage and S phase accumulation, and enhances apoptosis in TP53-WT, BRAFV600E primary CRC organoid line RAH051T[1].
APO-50815 (90 nM; 2 h) significantly reduces pTyr15-CDK1 levels in MDA-MB-231HM cells, confirming intracellular WEE1 target engagement and functional inhibition[1].
APO-50815 (1 μM; up to 60 min at 37 °C) has poor metabolic stability in human and mouse liver microsomes, with short half-lives and high intrinsic clearances indicating rapid metabolism[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:CRC organoid lines PM003 and PM025; TP53-mutated liver metastatic CRC organoid line QEH039LM; primary CRC organoids
-
Concentration:0.1 nM; 1 nM; 10 nM; 100 nM; 1 μM; 10 μM; 100 μM
-
Incubation Time:5 days
-
Result:Potently reduced viability of TP53-mutated peritoneal metastatic CRC organoid lines PM003 (IC50 = 37 nM) and PM025 (IC50 = 74 nM).
Potently reduced viability of TP53-mutated liver metastatic CRC organoid line QEH039LM (IC50 = 50 nM) and exhibited enhanced activity against the KRASG12X-mutated, WEE1 inhibitor-resistant line QEH042LM (IC50 = 633 nM).
Potently and selectively reduced viability of primary CRC organoids across diverse mutation profiles, with exceptional therapeutic indices of 238 (RAH051), 146 (RAH035), and 129 (RAH057).
-
Cell Line:TP53-WT, BRAFV600E primary CRC organoid line RAH051T
-
Concentration:300 nM
-
Incubation Time:48 h
-
Result:Significantly reduced active cycling, amplified DNA damage and S phase accumulation, and enhanced apoptosis.
-
Cell Line:TP53-mutated MDA-MB-231HM triple negative breast cancer cells
-
Concentration:90 nM
-
Incubation Time:2 h
-
Result:Significantly reduced levels of pTyr15-CDK1, confirming functional inhibition of WEE1 activity and successful cell membrane permeation to engage the target.
Chemical Information
-
Molecular Weight 527.64
-
Formula C28H29N7O2S
-
SMILES
C=CCN1C(C2=CN=C(N=C2N1C3=CC=CC(C4(CSC4)O)=N3)NC5=CC6=C(C7(CN(C6)C)CC7)C=C5)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Genotoxicity/Mutagenicity Study
The bacterial reverse mutation assay detects point mutations that restore amino-acid prototrophy in auxotrophic Salmonella typhimurium or Escherichia coli tester strains; after exposure to a test article, mutagenic activity is read out as an increased number of revertant colonies on minimal agar compared with the vehicle control. The assay uses tester strains with different mutation targets so that base-substitution and frameshift mutagens can be detected, and testing is performed with and without exogenous mammalian metabolic activation because some chemicals require biotransformation to become mutagenic.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)